Chronic granulomatous disease: A review of the infectious and inflammatory complications

Clinical and Molecular Allergy

Volumn 9, Issue , 2011, Pages

  Song, EunKyung ^a   Jaishankar, Gayatri B ^a   Saleh, Hana ^a   Jithpratuck, Warit ^a   Sahni, Ryan ^a   Krishnaswamy, Guha ^a,b  

^a East Tennessee State University   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CARBAPENEM; COTRIMOXAZOLE; GAMMA INTERFERON; GLUCOCORTICOID; ITRACONAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STEROID; SUPEROXIDE; VANCOMYCIN; VORICONAZOLE;

ABSCESS; ACALCULOUS CHOLECYSTITIS; AIRWAY OBSTRUCTION; APPENDICITIS; ARTERY OCCLUSION; ASCITES; ASPERGILLOSIS; ATOPIC DERMATITIS; BLEPHAROKERATOCONJUNCTIVITIS; BRAIN ABSCESS; BRAIN INFECTION; BURKHOLDERIA INFECTION; CANDIDIASIS; CHOROIDO RETINAL SCAR; CHRONIC GLOMERULONEPHRITIS; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; COLITIS; CONGENITAL ARTERIOVENOUS HEMANGIOMA; CONJUNCTIVITIS; DIAGNOSTIC PROCEDURE; DIARRHEA; DIGESTIVE SYSTEM FISTULA; DIGESTIVE SYSTEM ULCER; DISCOID LUPUS ERYTHEMATOSUS; FACIAL GRANULOMATA; GASTROINTESTINAL ABSCESS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL OBSTRUCTION; GASTROINTESTINAL STRICTURE; GENE THERAPY; GENETICS; GRANULOMA; HEMANGIOMA; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFLAMMATION; KERATITIS; KIDNEY AMYLOIDOSIS; KIDNEY DISEASE; LIVER ABSCESS; LUNG INFECTION; MALABSORPTION; MARGINAL KERATITIS; MENINGEAL CYST; MENINGITIS; MORBIDITY; MORTALITY; MYCOSIS; NOCARDIOSIS; OSTEOMYELITIS; PHAGOCYTE; PNEUMONIA; PSEUDOMONAS INFECTION; RECTUM ABSCESS; REVIEW; SALMONELLA ENTERITIDIS; SCAR; SEBORRHEIC DERMATITIS; SEPTICEMIA; STAPHYLOCOCCUS INFECTION; STEM CELL TRANSPLANTATION; STOMACH OBSTRUCTION; UREMIA; UROGENITAL TRACT DISEASE;

EID: 79957576822     PISSN: None     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/1476-7961-9-10     Document Type: Review

References (192)

1. Janeway CA, et al. Hypergammaglobulinemia associated with severe, recurrent and chronic non-specific infection. Am J Dis Child 1954, 88:388-392.
2. Landing BH, Shirkey HS. A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes. Pediatrics 1957, 20:431-438.
3. Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child 1959, 97:387-408.
4. Seger RA. Advances in the diagnosis and treatment of chronic granulomatous disease. Curr Opin Hematol 2010,
5. Editorial Microbial killing by neutrophils. Lancet 1976, 1:1393-1394. Editorial.
6. Phagocytic defects II Abnormalities of the respiratory burst. Hematol Oncol Clin North Am 1988, 2:185-336. Phagocytic defects II.
7. Babior BM. The respiratory burst oxidase. Hematol Oncol Clin North Am 1988, 2:201-212.
8. Borregaard N. Activation of phagocytes. Eur J Clin Invest 1985, 15:240-241. 10.1111/j.1365-2362.1985.tb00176.x, 3935452.
9. Holmes B, et al. Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet 1966, 1:1225-1228.
10. Quie PG, et al. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest 1967, 46:668-679. 10.1172/JCI105568, 442050, 6021213.
11. Baehner RL, Nathan DG. Leukocyte oxidase: defective activity in chronic granulomatous disease. Science 1967, 155:835-836. 10.1126/science.155.3764.835, 6018195.
12. Baehner RL, Nathan DG. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 1968, 278:971-976. 10.1056/NEJM196805022781801, 4384563.
13. Baehner RL, Karnovsky ML. Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease. Science 1968, 162:1277-1279. 10.1126/science.162.3859.1277, 4387010.
14. Curnutte JT, Whitten DM, Babior BM. Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med 1974, 290:593-597. 10.1056/NEJM197403142901104, 4359964.
15. Hohn DC, Lehrer RI. NADPH oxidase deficiency in X-linked chronic granulomatous disease. J Clin Invest 1975, 55:707-713. 10.1172/JCI107980, 301806, 235560.
16. Segal AW. Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 1987, 326:88-91. 10.1038/326088a0, 3821877.
17. Baehner RL. Chronic granulomatous disease of childhood: clinical, pathological, biochemical, molecular, and genetic aspects of the disease. Pediatr Pathol 1990, 10:143-153. 10.3109/15513819009067103, 2107536.
18. Umei T, Takeshige K, Minakami S. NADPH-binding component of the superoxide-generating oxidase in unstimulated neutrophils and the neutrophils from the patients with chronic granulomatous disease. Biochem J 1987, 243:467-472. 1147878, 3632631.
19. Curnutte JT, Kuver R, Scott PJ. Activation of neutrophil NADPH oxidase in a cell-free system. Partial purification of components and characterization of the activation process. J Biol Chem 1987, 262:5563-5569.
20. Bjorgvinsdottir H, Zhen L, Dinauer MC. Cloning of murine gp91phox cDNA and functional expression in a human X-linked chronic granulomatous disease cell line. Blood 1996, 87:2005-2010.
21. Casimir C, et al. Identification of the defective NADPH-oxidase component in chronic granulomatous disease: a study of 57 European families. Eur J Clin Invest 1992, 22:403-406. 10.1111/j.1365-2362.1992.tb01481.x, 1633835.
22. Curnutte JT. Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clin Immunol Immunopathol 1993, 67:S2-15. 10.1006/clin.1993.1078, 8500277.
23. Roos D. The genetic basis of chronic granulomatous disease. Immunol Rev 1994, 138:121-157. 10.1111/j.1600-065X.1994.tb00850.x, 8070813.
24. Kinnon C, Levinsky R. The molecular basis of X-linked immunodeficiency disease. J Inherit Metab Dis 1992, 15:674-682. 10.1007/BF01799623, 1528025.
25. Bertelson CJ, et al. Localization of the McLeod locus (XK) within Xp21 by deletion analysis. Am J Hum Genet 1988, 42:703-711. 1715185, 3358422.
26. Brown J, et al. Analysis of three deletion breakpoints in Xp21.1 and the further localization of RP3. Genomics 1996, 37:200-210. 10.1006/geno.1996.0543, 8921393.
27. Al-Khuwaitir TS, et al. Chronic granulomatous disease with recurrent hepatic abscesses in an adult. Saudi Med J 2007, 28:1593-1596.
28. Aliabadi H, Gonzalez R, Quie PG. Urinary tract disorders in patients with chronic granulomatous disease. N Engl J Med 1989, 321:706-708. 10.1056/NEJM198909143211102, 2770801.
29. Becker CE, Graddick SL, Roy TM. Patterns of chronic granulomatous disease. J Ky Med Assoc 1993, 91:447-450.
30. Winkelstein JA, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000, 79:155-169.
31. Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr 2007, 166:1099-1117. 10.1007/s00431-007-0527-7, 17551753.
32. Alsultan A, et al. Chronic granulomatous disease presenting with disseminated intracranial aspergillosis. Pediatr Blood Cancer 2006, 47:107-110. 10.1002/pbc.20426, 15931655.
33. Ahlin A, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 1995, 84:1386-1394. 10.1111/j.1651-2227.1995.tb13575.x, 8645957.
34. Kobayashi S, et al. Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan. Eur J Pediatr 2008, 167:1389-1394. 10.1007/s00431-008-0680-7, 18335239.
35. Jones LB, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol 2008, 152:211-218. 10.1111/j.1365-2249.2008.03644.x, 2384093, 18410635.
36. Liese J, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000, 137:687-693. 10.1067/mpd.2000.109112, 11060536.
37. Liese JG, et al. Chronic granulomatous disease in adults. Lancet 1996, 347:220-223. 10.1016/S0140-6736(96)90403-1, 8551880.
38. van den Berg JM, et al. Chronic granulomatous disease: the European experience. PLoS One 2009, 4:e5234. 10.1371/journal.pone.0005234, 2668749, 19381301.
39. Foster CB, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 1998, 102:2146-2155. 10.1172/JCI5084, 509169, 9854050.
40. Kawashima A, et al. Pulmonary Aspergillus chest wall involvement in chronic granulomatous disease: CT and MRI findings. Skeletal Radiol 1991, 20:487-493.
41. Altman AR. Thoracic wall invasion secondary to pulmonary aspergillosis: a complication of chronic granulomatous disease of childhood. AJR Am J Roentgenol 1977, 129:140-142.
42. Adinoff AD, et al. Chronic granulomatous disease and Pneumocystis carinii pneumonia. Pediatrics 1982, 69:133-134.
43. Markus MR. Chronic granulomatous disease and Pneumocystis carinii pneumonia. S Afr Med J 1983, 63:350.
44. Pedersen FK, et al. Refractory Pneumocystis carinii infection in chronic granulomatous disease: successful treatment with granulocytes. Pediatrics 1979, 64:935-938.
45. Allen DM, Chng HH. Disseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease. J Infect 1993, 26:83-86. 10.1016/0163-4453(93)97000-N, 8454891.
46. Chudwin DS, et al. Aspergillus pneumonia in chronic granulomatous disease: recurrence and long-term outcome. Acta Paediatr Scand 1982, 71:915-917. 10.1111/j.1651-2227.1982.tb09548.x, 7158331.
47. Chusid MJ, Sty JR, Wells RG. Pulmonary aspergillosis appearing as chronic nodular disease in chronic granulomatous disease. Pediatr Radiol 1988, 18:232-234. 10.1007/BF02390402, 3368249.
48. Conrad DJ, et al. Microgranulomatous aspergillosis after shoveling wood chips: report of a fatal outcome in a patient with chronic granulomatous disease. Am J Ind Med 1992, 22:411-418. 10.1002/ajim.4700220313, 1519622.
49. Kelly JK, et al. Fatal Aspergillus pneumonia in chronic granulomatous disease. Am J Clin Pathol 1986, 86:235-240.
50. Kosut JS, Kamani NR, Jantausch BA. One-month-old infant with multilobar round pneumonias. Pediatr Infect Dis J 2006, 25:95-97. 10.1097/01.inf.0000195717.40250.8b, 16395119.
51. Asensi V, et al. Visceral leishmaniasis and other severe infections in an adult patient with p47-phox-deficient chronic granulomatous disease. Infection 2000, 28:171-174. 10.1007/s150100050074, 10879644.
52. Carnide EG, et al. Clinical and laboratory aspects of chronic granulomatous disease in description of eighteen patients. Pediatr Allergy Immunol 2005, 16:5-9. 10.1111/j.1399-3038.2005.00225.x, 15693905.
53. Clegg HW, Ephros M, Newburger PE. Pseudomonas cepacia pneumonia in chronic granulomatous disease. Pediatr Infect Dis 1986, 5:111.
54. O'Neil KM, et al. Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr 1986, 108:940-942. 10.1016/S0022-3476(86)80934-9, 3486968.
55. Sieber OF, Fulginiti VA. Pseudomonas cepacia pneumonia in a child with chronic granulomatous disease and selective IgA deficiency. Acta Paediatr Scand 1976, 65:519-520. 10.1111/j.1651-2227.1976.tb04924.x, 937004.
56. Ephros M, et al. Legionella gormanii pneumonia in a child with chronic granulomatous disease. Pediatr Infect Dis J 1989, 8:726-727. 10.1097/00006454-198910000-00014, 2812918.
57. Peerless AG, et al. Legionella pneumonia in chronic granulomatous disease. J Pediatr 1985, 106:783-785. 10.1016/S0022-3476(85)80355-3, 3998918.
58. McNeil MM, et al. Disseminated Nocardia transvalensis infection: an unusual opportunistic pathogen in severely immunocompromised patients. J Infect Dis 1992, 165:175-178. 10.1093/infdis/165.1.175, 1727888.
59. Johnston HC, et al. Nocardia pneumonia in a neonate with chronic granulomatous disease. Pediatr Infect Dis J 1989, 8:526-528. 10.1097/00006454-198908000-00011, 2505222.
60. Jonsson S, et al. Recurrent Nocardia pneumonia in an adult with chronic granulomatous disease. Am Rev Respir Dis 1986, 133:932-934.
61. Shetty AK, Arvin AM, Gutierrez KM. Nocardia farcinica pneumonia in chronic granulomatous disease. Pediatrics 1999, 104:961-964. 10.1542/peds.104.4.961, 10506241.
62. Kato M, et al. [Mycoplasma pneumoniae pneumonia in patients with chronic granulomatous disease]. Kansenshogaku Zasshi 1983, 57:823-827.
63. Kenney RT, et al. Invasive infection with Sarcinosporon inkin in a patient with chronic granulomatous disease. Am J Clin Pathol 1990, 94:344-350.
64. Lee PP, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J 2008, 27:224-230. 10.1097/INF.0b013e31815b494c, 18277931.
65. Lestini BJ, Church JA. Trichosporon pullulans as a complication of chronic granulomatous disease in a patient undergoing immunosuppressive therapy for inflammatory bowel disease. Pediatr Infect Dis J 2006, 25:87-89. 10.1097/01.inf.0000195641.69380.a0, 16395115.
66. Moylett EH, Chinen J, Shearer WT. Trichosporon pullulans infection in 2 patients with chronic granulomatous disease: an emerging pathogen and review of the literature. J Allergy Clin Immunol 2003, 111:1370-1374. 10.1067/mai.2003.1522, 12789241.
67. Maranan MC, et al. Pneumonic tularemia in a patient with chronic granulomatous disease. Clin Infect Dis 1997, 25:630-633. 10.1086/513777, 9314451.
68. Meis JF, et al. Rapidly fatal Q-fever pneumonia in a patient with chronic granulomatous disease. Infection 1992, 20:287-289. 10.1007/BF01710798, 1428185.
69. Pastorino AC, et al. Acremonium kiliense infection in a child with chronic granulomatous disease. Braz J Infect Dis 2005, 9:529-534. 10.1590/S1413-86702005000600014, 16410951.
70. Paz HL, et al. Primary pulmonary botryomycosis. A manifestation of chronic granulomatous disease. Chest 1992, 101:1160-1162. 10.1378/chest.101.4.1160, 1555442.
71. Roilides E, et al. Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J Clin Microbiol 1999, 37:18-25. 84155, 9854057.
72. Ross JP, et al. Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases. Clin Infect Dis 1995, 21:1291-1293. 10.1093/clinids/21.5.1291, 8589158.
73. Siddiqui S, et al. Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis 2007, 45:673-681. 10.1086/520985, 17712749.
74. Uzel G, et al. Respiratory syncytial virus infection in patients with phagocyte defects. Pediatrics 2000, 106:835-837. 10.1542/peds.106.4.835, 11015530.
75. Wenger JD, et al. Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen. Ann Intern Med 1989, 110:888-892.
76. Trawick D, et al. Eosinophilic pneumonia as a presentation of occult chronic granulomatous disease. Eur Respir J 1997, 10:2166-2170. 10.1183/09031936.97.10092166, 9311521.
77. Narchi H, Gammoh S. Multiple nodular pneumonitis in a three-week-old female infant. Pediatr Infect Dis J 1999, 18:471-486.
78. Palestine AG, et al. Ocular findings in patients with neutrophil dysfunction. Am J Ophthalmol 1983, 95:598-604.
79. Djalilian AR, et al. Keratitis caused by Candida glabrata in a patient with chronic granulomatous disease. Am J Ophthalmol 2001, 132:782-783. 10.1016/S0002-9394(01)01091-1, 11704043.
80. Andersen SR. Vascular lesion (arteriovenous aneurysm or haemangioma) of the orbit in a case of chronic granulomatous disease. Ophthalmologica 1976, 173:145-151. 10.1159/000307875, 1066591.
81. Bhat SV, et al. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand J Infect Dis 2007, 39:87-90. 10.1080/00365540600786564, 17366022.
82. Hipolito E, et al. Alternaria infectoria brain abscess in a child with chronic granulomatous disease. Eur J Clin Microbiol Infect Dis 2009, 28:377-380. 10.1007/s10096-008-0623-2, 18815820.
83. Ma JS, et al. Brain abscess caused by Salmonella enterica subspecies houtenae in a patient with chronic granulomatous disease. J Microbiol Immunol Infect 2003, 36:282-284.
84. Narita M. A case of chronic granulomatous disease in which the patient survived a recurrence of suspected Aspergillus brain abscess. Kansenshogaku Zasshi 1999, 73:783-786.
85. Saulsbury FT. Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin Infect Dis 2001, 32:E137-E139. 10.1086/320158, 11317265.
86. Hadfield MG, et al. Brain lesions in chronic granulomatous disease. Acta Neuropathol 1991, 81:467-470. 10.1007/BF00293469, 2028750.
87. Walker DH, Okiye G. Chronic granulomatous disease involving the central nervous system. Pediatr Pathol 1983, 1:159-167. 10.3109/15513818309040653, 6687273.
88. Riggs JE, et al. Pigmented, lipid-laden histiocytes in the central nervous system in chronic granulomatous disease of childhood. J Child Neurol 1989, 4:61-63. 10.1177/088307388900400111, 2918213.
89. Leto TL, et al. Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science 1990, 248:727-730. 10.1126/science.1692159, 1692159.
90. Patiroglu T, et al. Atypical presentation of chronic granulomatous disease in an adolescent boy with frontal lobe located Aspergillus abscess mimicking intracranial tumor. Childs Nerv Syst 2010, 26:149-154. 10.1007/s00381-009-1003-7, 19859718.
91. Bukhari E, Alrabiaah A. First case of extensive spinal cord infection with Aspergillus nidulans in a child with chronic granulomatous disease. J Infect Dev Ctries 2009, 3:321-323.
92. Turgut M. Fungal granuloma of the brain caused by Aspergillus in an adolescent boy with chronic granulomatous disease. Childs Nerv Syst 2010, 26:733-734. 10.1007/s00381-010-1149-3, 20396894.
93. Garel D, et al. [Streptococcus group B tardive meningitis revealing chronic septic granulomatosis]. Ann Pediatr (Paris) 1989, 36:35-37.
94. Fleischmann J, Church JA, Lehrer RI. Primary Candida meningitis and chronic granulomatous disease. Am J Med Sci 1986, 291:334-341. 10.1097/00000441-198605000-00009, 3706396.
95. Barton LL, et al. Gastrointestinal complications of chronic granulomatous disease: case report and literature review. Clin Pediatr (Phila) 1998, 37:231-236.
96. Mulholland MW, Delaney JP, Simmons RL. Gastrointestinal complications of chronic granulomatous disease: surgical implications. Surgery 1983, 94:569-575.
97. Huang A, Abbasakoor F, Vaizey CJ. Gastrointestinal manifestations of chronic granulomatous disease. Colorectal Dis 2006, 8:637-644. 10.1111/j.1463-1318.2006.01030.x, 16970572.
98. Saul RA. Gastric outlet obstruction in chronic granulomatous disease. J Pediatr 1989, 114:505.
99. Born M, Willinek WA, Hassan C. [Gastric outlet obstruction in chronic granulomatous disease]. Z Gastroenterol 2002, 40:511-516. 10.1055/s-2002-32799, 12122599.
100. Dickerman JD, Colletti RB, Tampas JP. Gastric outlet obstruction in chronic granulomatous disease of childhood. Am J Dis Child 1986, 140:567-570.
101. Johnson FE, et al. Gastric outlet obstruction due to X-linked chronic granulomatous disease. Surgery 1975, 78:217-223.
102. Varma VA, et al. Chronic granulomatous disease of childhood presenting as gastric outlet obstruction. Am J Surg Pathol 1982, 6:673-676. 10.1097/00000478-198210000-00009, 7180966.
103. Hartenberg MA, Kodroff MB. Chronic granulomatous disease of childhood. Probable diffuse gastric involvement. Pediatr Radiol 1984, 14:57-58. 10.1007/BF02386736, 6694864.
104. Danziger RN, et al. Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease. J Pediatr 1993, 122:303-305. 10.1016/S0022-3476(06)80138-1, 8429451.
105. Caksen H, et al. Recurrent multiple hepatic abscesses, hepatic calcification and congenital hearing loss in a child with chronic granulomatous disease. Acta Paediatr Taiwan 2004, 45:249-252.
106. Berlin CM, et al. Hepatic granulomata. Presenting with prolonged fever. Resolution with anti-inflammatory treatment. Clin Pediatr (Phila) 1990, 29:339-342.
107. Chen LE, et al. Cut it out: Managing hepatic abscesses in patients with chronic granulomatous disease. J Pediatr Surg 2003, 38:709-713. 10.1016/jpsu.2003.50189, 12720176.
108. Fehon R, et al. Two-year-old boy with cervical and liver abscesses. J Paediatr Child Health 2008, 44:670-672. 10.1111/j.1440-1754.2008.01398.x, 19012643.
109. Garel LA, et al. Liver involvement in chronic granulomatous disease: the role of ultrasound in diagnosis and treatment. Radiology 1984, 153:117-121.
110. Grund KE, Klotter HJ, Lemmel EM. Chronic granulomatosis as a rare cause of recurrent liver abscess. Med Welt 1982, 33:202-203.
111. Larsen LR, Raffensperger J. Liver abscess. J Pediatr Surg 1979, 14:329-331. 10.1016/S0022-3468(79)80493-5, 480097.
112. Marchetti F, et al. A 7-month-old boy with liver abscesses. J Pediatr Gastroenterol Nutr 2010, 50:117. 10.1097/MPG.0b013e3181c615b1, 20038847.
113. Nakhleh RE, Glock M, Snover DC. Hepatic pathology of chronic granulomatous disease of childhood. Arch Pathol Lab Med 1992, 116:71-75.
114. Castro M, et al. Ascites as an unusual manifestation of chronic granulomatous disease in childhood. Pediatr Med Chir 1992, 14:317-319.
115. Feld JJ, et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008, 134:1917-1926. 10.1053/j.gastro.2008.02.081, 2583937, 18439425.
116. Hussain N, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007, 45:675-683. 10.1002/hep.21524, 17326162.
117. Ament ME, Ochs HD, Davis SD. Structure and function of the gastrointestinal tract in primary immunodeficiency syndromes. A study of 39 patients. Medicine (Baltimore) 1973, 52:227-248.
118. Ament ME, Ochs HD. Gastrointestinal manifestations of chronic granulomatous disease. N Engl J Med 1973, 288:382-387. 10.1056/NEJM197302222880802, 4684040.
119. Hadzic N, et al. Successful orthotopic liver transplantation for fulminant liver failure in a child with autosomal recessive chronic granulomatous disease. Transplantation 1995, 60:1185-1186. 10.1097/00007890-199511270-00023, 7482731.
120. Hague RA, et al. Resolution of hepatic abscess after interferon gamma in chronic granulomatous disease. Arch Dis Child 1993, 69:443-445. 10.1136/adc.69.4.443, 1029553, 8259876.
121. Chin TW, et al. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr 1987, 111:349-352. 10.1016/S0022-3476(87)80452-3, 3625401.
122. Metin A, et al. Gastric antral stricture in a patient with chronic granulomatous disease. Turk J Pediatr 1999, 41:369-373.
123. Safe AF, et al. Relapsing Salmonella enteritidis infection in a young adult male with chronic granulomatous disease. Postgrad Med J 1991, 67:198-201. 10.1136/pgmj.67.784.198, 2398989, 2041855.
124. Buescher ES, Gallin JI. Stature and weight in chronic granulomatous disease. J Pediatr 1984, 104:911-913. 10.1016/S0022-3476(84)80497-7, 6726526.
125. Frifelt JJ, et al. Chronic granulomatous disease associated with chronic glomerulonephritis. Acta Paediatr Scand 1985, 74:152-157. 10.1111/j.1651-2227.1985.tb10940.x, 3984721.
126. Grossniklaus HE, Frank KE, Jacobs G. Chorioretinal lesions in chronic granulomatous disease of childhood. Clinicopathologic correlations. Retina 1988, 8:270-274. 10.1097/00006982-198808040-00009, 3231919.
127. Myerson DA, Rosenfield AT. Renal aspergillosis: a report of two cases. J Can Assoc Radiol 1977, 28:214-216.
128. Johansen KS, et al. Chronic granulomatous disease presenting as xanthogranulomatous pyelonephritis in late childhood. J Pediatr 1982, 100:98-100. 10.1016/S0022-3476(82)80246-1, 6799633.
129. Peces R, Ablanedo P, Seco M. [Amyloidosis associated with chronic granulomatous disease in a patient with a renal transplant and recurrent urinary tract infections]. Nefrologia 2002, 22:486-491.
130. Walther MM, et al. The urological manifestations of chronic granulomatous disease. J Urol 1992, 147:1314-1318.
131. Jung K, et al. Severe infectious complications in a girl suffering from atopic dermatitis were found to be due to chronic granulomatous disease. Acta Derm Venereol 1993, 73:433-436.
132. Ahmed I. Clinicopathologic challenge. Childhood granulomatous peri-orificial dermatitis with extra-facial lesions. Int J Dermatol 2007, 46:143-145. 10.1111/j.1365-4632.2007.03089.x, 17269963.
133. Luis-Montoya P, Saez-de Ocariz MM, Vega-Memije ME. Chronic granulomatous disease: two members of a single family with different dermatologic manifestations. Skinmed 2005, 4:320-322. 10.1111/j.1540-9740.2005.03927.x, 16282759.
134. Dohil M, et al. Cutaneous manifestations of chronic granulomatous disease. A report of four cases and review of the literature. J Am Acad Dermatol 1997, 36:899-907. 10.1016/S0190-9622(97)80269-1, 9204051.
135. Gallin JI, Buescher ES. Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease. Inflammation 1983, 7:227-232. 10.1007/BF00917259, 6681319.
136. Boyanton BL, et al. Burkholderia gladioli osteomyelitis in association with chronic granulomatous disease: case report and review. Pediatr Infect Dis J 2005, 24:837-839. 10.1097/01.inf.0000177285.44374.dc, 16148855.
137. Al-Tawfiq JA, Al-Abdely HM. Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma. Med Mycol 2010, 48:537-541. 10.3109/13693780903325290, 19886765.
138. Dotis J, Roilides E. Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Int J Infect Dis 2004, 8:103-110. 10.1016/j.ijid.2003.06.001, 14732328.
139. Dotis J, et al. Femoral osteomyelitis due to Aspergillus nidulans in a patient with chronic granulomatous disease. Infection 2003, 31:121-124. 10.1007/s15010-002-2167-1, 12682820.
140. Hodiamont CJ, et al. Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery. Med Mycol 2009, 47:217-220. 10.1080/13693780802545600, 19101840.
141. Kozlowski K. Dactylitis secondary to chronic granulomatous disease (report of a case). Radiol Diagn (Berl) 1976, 17:347-350.
142. Cohen-Abbo A, Edwards KM. Multifocal osteomyelitis caused by Paecilomyces varioti in a patient with chronic granulomatous disease. Infection 1995, 23:55-57. 10.1007/BF01710060, 7744494.
143. Davis CM, et al. Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease. Pediatr Infect Dis J 2007, 26:655-656. 10.1097/INF.0b013e3180616cd0, 17596815.
144. Gill PJ, et al. Chronic granulomatous disease presenting with osteomyelitis: favorable response to treatment with interferon-gamma. J Pediatr Orthop 1992, 12:398-400. 10.1097/01241398-199205000-00022, 1573009.
145. Isotani H, et al. Treatment with rhG-CSF for osteomyelitis in a patient with p47-phox-deficient chronic granulomatous disease. Ann Hematol 1997, 75:243-246. 10.1007/s002770050351, 9433384.
146. Brown JR, et al. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). J Leukoc Biol 2003, 73:591-599. 10.1189/jlb.1202599, 12714573.
147. Bonta IL, Adolfs MJ, Parnham MJ. Distribution and further studies on the activity of prostaglandin E in chronic granulomatous inflammation. Agents Actions Suppl 1979, 121-132.
148. Bylund J, et al. Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. Eur J Immunol 2007, 37:1087-1096. 10.1002/eji.200636651, 17330823.
149. Carp H, Janoff A. Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro. J Clin Invest 1980, 66:987-995. 10.1172/JCI109968, 371535, 6253528.
150. Hampton MB, et al. Oxidant-mediated phosphatidylserine exposure and macrophage uptake of activated neutrophils: possible impairment in chronic granulomatous disease. J Leukoc Biol 2002, 71:775-781.
151. Govan JR. The Burkholderia cepacia complex and cytokine induction: an inflammatory tale. Pediatr Res 2003, 54:294-296. 10.1203/01.PDR.0000076660.83194.EC, 12761357.
152. George-Chandy A, et al. Th17 development and autoimmune arthritis in the absence of reactive oxygen species. Eur J Immunol 2008, 38:1118-1126. 10.1002/eji.200737348, 18383034.
153. Petersen JE, et al. Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease. J Invest Dermatol 2002, 424-429.
154. Schappi M, et al. Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-deficient mice. J Pathol 2008, 214:434-444.
155. Casale AJ, et al. Bilateral complete ureteral obstruction and renal insufficiency secondary to granulomatous disease. J Urol 1989, 142:812-814.
156. Francke U, et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet 1985, 37:250-267. 1684578, 4039107.
157. Frey D, et al. Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus. Blood 1988, 71:252-255.
158. Marsh WL, Uretsky SC, Douglas SD. Antigens of the Kell blood group system on neutrophils and monocytes: their relation to chronic granulomatous disease. J Pediatr 1975, 87:1117-1120. 10.1016/S0022-3476(75)80124-7, 52702.
159. Ito K, et al. Kell phenotypes in 15 Japanese patients with chronic granulomatous disease. Vox Sang 1979, 37:39-40. 10.1111/j.1423-0410.1979.tb02266.x, 494579.
160. Brzica SM, et al. Chronic granulomatous disease and the Mcleod phenotype. Successful treatment of infection with granulocyte transfusions resulting in subsequent hemolytic transfusion reaction. Mayo Clin Proc 1977, 52:153-156.
161. Brandrup F, et al. Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous disease. Br J Dermatol 1981, 104:495-505. 10.1111/j.1365-2133.1981.tb08163.x, 7236510.
162. Garioch JJ, et al. Dermatoses in five related female carriers of X-linked chronic granulomatous disease. Br J Dermatol 1989, 121:391-396. 10.1111/j.1365-2133.1989.tb01434.x, 2803962.
163. Humbert JR, et al. Frequency of the carrier state for X-linked chronic granulomatous disease among females with lupus erythematosus. Clin Genet 1976, 10:16-20.
164. Rupec RA, et al. Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease. Eur J Dermatol 2000, 10:184-189.
165. Sillevis Smitt JH, et al. Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol 1990, 122:643-650. 10.1111/j.1365-2133.1990.tb07286.x, 2354117.
166. Johnston RB, Harbeck RJ, Johnston RB. Recurrent severe infections in a girl with apparently variable expression of mosaicism for chronic granulomatous disease. J Pediatr 1985, 106:50-55. 10.1016/S0022-3476(85)80463-7, 3965681.
167. Kragballe K, et al. Relation of monocyte and neutrophil oxidative metabolism to skin and oral lesions in carriers of chronic granulomatous disease. Clin Exp Immunol 1981, 43:390-398. 1537283, 7273485.
168. Martin-Villa JM, et al. Higher incidence of autoantibodies in X-linked chronic granulomatous disease carriers: random X-chromosome inactivation may be related to autoimmunity. Autoimmunity 1999, 31:261-264.
169. Gerba WM, et al. Chronic granulomatous disease and selective IgA deficiency. Am J Pediatr Hematol Oncol 1982, 4:155-160.
170. Shamsian BS, et al. Autosomal recessive chronic granulomatous disease, IgA deficiency and refractory autoimmune thrombocytopenia responding to Anti-CD20 monoclonal antibody. Iran J Allergy Asthma Immunol 2008, 7:181-184.
171. [The NBT test in pediatrics]. Recenti Prog Med 1976, 61:219-231.
172. Ayatollahi M, et al. A fast and easy nitroblue tetrazolium method for carrier screening and prenatal detection of chronic granulomatous disease. Arch Iran Med 2006, (9:):335-338.
173. Budny JL, Grotke NC, MacGillivray M. Nitroblue tetrazolium dye reduction: diagnostic value in children with febrile illnesses. N Y State J Med 1976, 76:877-881.
174. Crockard AD, et al. Diagnosis and carrier detection of chronic granulomatous disease in five families by flow cytometry. Int Arch Allergy Immunol 1997, 114:144-152. 10.1159/000237660, 9338608.
175. Elloumi HZ, Holland SM. Diagnostic assays for chronic granulomatous disease and other neutrophil disorders. Methods Mol Biol 2007, 412:505-523. 10.1007/978-1-59745-467-4_31, 18453131.
176. Emmendorffer A, et al. A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine J. Immunol Methods 1990, 131:269-275.
177. Emmendorffer A, et al. Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Cytometry 1994, 18:147-155. 10.1002/cyto.990180306, 7813334.
178. Epling CL, et al. Neutrophil function screening in patients with chronic granulomatous disease by a flow cytometric method. Cytometry 1992, 13:615-620. 10.1002/cyto.990130609, 1451593.
179. Chien SC, et al. Rapid prenatal diagnosis of X-linked chronic granulomatous disease using a denaturing high-performance liquid chromatography (DHPLC) system. Prenat Diagn 2003, 23:1092-1096. 10.1002/pd.761, 14691999.
180. Klaudel-Dreszler MA, et al. Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC. Int J Hematol 2009, 90:571-575. 10.1007/s12185-009-0433-z, 19866337.
181. de BM, et al. Prenatal diagnosis in a family with X-linked chronic granulomatous disease with the use of the polymerase chain reaction. Prenat Diagn 1992, 12:773-777. 10.1002/pd.1970120910, 1438069.
182. Johnston RB. Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 2001, 8:17-22. 10.1097/00062752-200101000-00004, 11138621.
183. lekst S, et al. Surgery and granulocyte transfusions for life-threatening infections in chronic granulomatous disease. Helv Paediatr Acta 1985, 40:277-284.
184. Lekstrom-Himes JA, et al. Treatment with intralesional granulocyte instillations and interferon-gamma for a patient with chronic granulomatous disease and multiple hepatic abscesses. Clin Infect Dis 1994, 19:770-773. 10.1093/clinids/19.4.770, 7803648.
185. Del GI, et al. Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. Ann Hematol 2003, 82:189-192.
186. Bhattacharya A, et al. Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease. Bone Marrow Transplant 2003, 31:403-405. 10.1038/sj.bmt.1703863, 12634733.
187. Seger RA. Modern management of chronic granulomatous disease. Br J Haematol 2008, 140:255-266. 10.1111/j.1365-2141.2007.06880.x, 18217895.
188. Barese CN, Goebel WS, Dinauer MC. Gene therapy for chronic granulomatous disease. Expert Opin Biol Ther 2004, 4:1423-1434. 10.1517/14712598.4.9.1423, 15335310.
189. Gene therapy for X-linked chronic granulomatous disease. Haematologica 2000, 85:450.
190. Becker S, et al. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. Hum Gene Ther 1998, %20;9:1561-1570.
191. Bjorgvinsdottir H, et al. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood 1997, 89:41-48.
192. Blaese RM. What is the status of gene therapy for primary immunodeficiency?. Immunol Res 2007, 38:274-284. 10.1007/s12026-007-0009-z, 17917032.